Rodman & Renshaw dropped Anadys Pharmaceuticals (NASDAQ:
ANDS) coverage today as the company's acquisition by Roche has been completed.
Loading...
Loading...
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
